Status:

COMPLETED

Prognostic Value of Endothelial Dysfunction and Coronary Complexity

Lead Sponsor:

Kumamoto University

Conditions:

Cardiovascular Disease

Eligibility:

All Genders

30-90 years

Brief Summary

The investigators test the additional clinical value of the physiological assessment of endothelial function to the morphological assessment of coronary complexity and classical risk score in predicti...

Detailed Description

The investigators enroll consecutive, stable high risk patients for cardiovascular events. The reactive hyperemia peripheral arterial tonometry index (RHI) was measured before coronary angiography and...

Eligibility Criteria

Inclusion

  • Stable, high-risk patients with diabetes mellitus, or more than two conventional coronary risk factors, who are referred for coronary angiography because of angina-like chest symptoms.

Exclusion

  • An ejection fraction \< 50%
  • Moderate to severe valvular heart disease
  • Cardiomyopathy
  • Allergy to latex
  • Significant endocrine, hepatic, renal, or inflammatory disease
  • cerebrovascular disease

Key Trial Info

Start Date :

August 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2017

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT00737945

Start Date

August 1 2006

End Date

March 1 2017

Last Update

August 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kumamoto University Hospital

Kumamoto, Japan, 860-8556

Prognostic Value of Endothelial Dysfunction and Coronary Complexity | DecenTrialz